Home › Cardiovascular Disease › California › Los Angeles
Cardiovascular Disease clinical trials in Los Angeles, CA
18 studies for Cardiovascular Disease are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Product Surveillance Registry
RecruitingObservational study
- Los Angeles, Los Angeles
Zenith® Fenestrated+ Clinical Study
Recruiting
- University of Southern California, Los Angeles
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- PIH Health Good Samaritan Hospital, Los Angeles
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Keck Hospital of the University of Southern California, USC, Los Angeles
- and 1 more
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Recruiting
- Cedars-Sinai Medical Center, Los Angeles
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Keck Medical Center USC, Los Angeles
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecruitingPhase 4Healthy volunteers welcome
- Cedars-Sinai Medical Center, Los Angeles
- VA Greater Los Angeles, Los Angeles
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Los Angeles
- Research Site, Los Angeles
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- InvivoCure, Los Angeles
WISE CVD - Continuation (WISE HFpEF)
RecruitingObservational study
- Cedars-Sinai Women's Heart Center, Los Angeles
Global Paradise System US Post Approval Study
RecruitingObservational study
- Cedars-Sinai Medical Center, Los Angeles
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Recruiting
- USC, Los Angeles
Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
Recruiting
- Keck School of Medicine, University of Southern California, Los Angeles
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- Keck School of Medicine of USC, Los Angeles
- UCLA Medical Center, Los Angeles
CANF-Comb-II PET-MR in Atherosclerosis Multisite
RecruitingObservational study
- Cedars Sinai Medical Center, Los Angeles
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
RecruitingPhase 2
- UCLA Center for Clinical AIDS Research and Education (CARE), Los Angeles
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
Recruiting
- Cedars-Sinai Medical Center, Los Angeles
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Recruiting
- Cedars - Sinai Medical Center, Los Angeles
PARTNER 3 Trial - Aortic Valve-in-Valve
Recruiting
- University of California Los Angeles, Los Angeles
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC28 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Nashville, TN18 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.